Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Pars Plana Vitrectomy

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT03586193Unknown

Pars Plana Vitrectomy Alone in the Treatment of Macular Schisis in High Myopic Eyes

NCT01862627CompletedPrimary

Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy

NCT01959724Not ApplicableCompleted

Macular Detachment Associated With Intrachoroidal Cavitation

Showing all 3 trials

Research Network

Common Treatments

  • Pars Plana Vitrectomy1
  • Vitrectomy1
  • Optical Coherence Tomography1

Active Sponsors

  • Kyorin University2
  • Aier School of Ophthalmology, Central South University1

Top Investigators

Related Conditions

  • Macular Detachment2
  • Normal Tension Glaucoma1
  • Retinal Disease1
  • Intrachoroidal Cavitation1

Activity Timeline